Wellumio has enrolled the first subject in the Portable MRI study of its magnetic resonance imaging (MRI) device, 'Axana' 0.1T, for stroke identification in emergency department patients. The two-part ...

More than 100 million people globally have had a stroke, but there are ways to reduce your risk and spot the signs of stroke ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Neuroscience is undergoing a profound transformation aided by developments in artificial intelligence (AI), particularly in how brain imaging techniques are ...

Abiodun Osibamowo, an experienced medical director and head of department of medicine at Reddington Multispecialist Hospital, ...

Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...

"A really big question that, at least I ask myself, is, 'How do we become who we are?'" University of Virginia psychology ...

According to Jean-Rémi King, leader of Meta’s “Brain & AI” research team, the system is able to determine what letter a skilled typist has pressed as much as 80% of the time, an accuracy high enough ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.